MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit : vimarsana.com

By Dean Seal


MiMedx Group said federal regulators are sticking to their position that its Axiofill product doesn't meet regulatory requirements for a certain classification sought by the...

Related Keywords

Georgia , United States , Joseph Capper , Public Health Service , Mimedx Group , Drug Administration , Dean Seal , Medx Group , Executive Joseph Capper , Dow Jones , Markets ,